|
Over 500 products: |
2019-nCoV Envelope Recombinant Protein | PSI-97-082 | ProSci | Summary Details |
|
2019-nCoV Nucleocapsid Recombinant Protein | PSI-97-077 | ProSci | Summary Details |
|
2019-nCoV Nucleocapsid Recombinant Protein | PSI-97-085 | ProSci | Summary Details |
|
ACE-2 Recombinant Protein | PSI-91-376 | ProSci | Summary Details |
|
ACE-2 Recombinant Protein | PSI-10-014 | ProSci | Summary Details |
|
ACE2 (human) (rec.) (Biotin) | AG-40B-0192B | AdipoGen Life Sciences | Summary Details |
|
ACE2 (human) (rec.) (His) | CHI-B232008 | Chimerigen | Summary Details |
|
ACE2 (IN1) Peptide | PSI-3215P | ProSci | Summary Details |
|
ACE2 (IN2) Peptide | PSI-3229P | ProSci | Summary Details |
|
ACE2 Antibody | PSI-3215 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-3217 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-3227 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-3229 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-70-543 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-10-531 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-10-600 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-10-601 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-10-602 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-10-603 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-24-030 | ProSci | Summary Details |
|
ACE2 Antibody | PSI-24-033 | ProSci | Summary Details |
|
ACE2 Antibody [3F1] | PSI-10-604 | ProSci | Summary Details |
|
ACE2 Antibody [AC18F] | PSI-36-031 | ProSci | Summary Details |
|
ACE2 Antibody [AC18F] (biotin) | PSI-36-032 | ProSci | Summary Details |
|
ACE2 Antibody [AC384] | PSI-36-038 | ProSci | Summary Details |
|
ACE2 Antibody [AC384] (biotin) | PSI-36-039 | ProSci | Summary Details |
|
ACE2 Peptide | PSI-3217P | ProSci | Summary Details |
|
ACE2 Peptide | PSI-3227P | ProSci | Summary Details |
|
ACE2 polyclonal antibody | PSI-11-034 | ProSci | Summary Details |
|
ACE2 Rabbit pAb | ELK-ES7007 | ELK Biotechnology | Summary Details |
|
Anti-ACE2 (17aa - Intermediate Domain) | LEI-A314 | Leinco Technologies | Summary Details |
|
Anti-ACE2 (CT) | LEI-A313 | Leinco Technologies | Summary Details |
|
anti-ACE2 (human) mAb (AC18F) (ATTO 488) | AG-20A-0032TD | AdipoGen Life Sciences | Summary Details |
|
Anti-ACE2 (Intermediate Domain) | LEI-A315 | Leinco Technologies | Summary Details |
|
Anti-ACE2 (NT) | LEI-A316 | Leinco Technologies | Summary Details |
|
Anti-COVID-19 Compound Library | TAR-L1710 | TargetMol | Summary Details |
|
Anti-COVID-19 Traditional Chinese Medicine Compound Library | TAR-L6720 | TargetMol | Summary Details |
|
Anti-SARS-CoV & CoV-2 NP Antibody [Clone 103] | LDG0135YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV & CoV-2 NP Antibody [Clone 104] | LDG0136YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV & CoV-2 NP Antibody Set | LDG0079YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV & CoV-2 NP IgA Antibody | LDG0078YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV & CoV-2 NP IgG Antibody | LDG0076YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV & CoV-2 NP IgM Antibody | LDG0077YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV & CoV-2 Spike IgA Antibody [Clone CR3022] | LDG0082YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV & CoV-2 Spike IgG Antibody [Clone CR3022] | LDG0080YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV & CoV-2 Spike IgM Antibody [Clone CR3022] | LDG0081YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV Envelope (CT) | LEI-S536 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV Matrix (CT) | LEI-S538 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV Matrix (NT) | LEI-S539 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV Spike (15aa - Intermediate Domain) | LEI-S543 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV Spike (16aa - Intermediate Domain) | LEI-S541 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV Spike (17aa - Intermediate Domain) | LEI-S542 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV Spike (NT) | LEI-S544 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Envelope (NT) | LEI-S537 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 NP Antibody [Clone 102-7] | LDG0083YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV-2 NP Antibody [Clone 109-5] | LDG0084YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV-2 NP Antibody [Clone 74-2] | LDG0158YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV-2 NP Antibody [Clone 88] | LDG0096YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) | LEI-LT7000 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-B9) | LEI-LT7080 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-B9) - Biotin | LEI-LT7081 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-B9) - HRP | LEI-LT7082 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-C5) | LEI-LT7030 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-C5) - Biotin | LEI-LT7031 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-C5) - HRP | LEI-LT7032 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-D4) | LEI-LT7060 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-D4) - Biotin | LEI-LT7061 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-D4) - HRP | LEI-LT7062 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-D6) | LEI-LT7070 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-D6) - Biotin | LEI-LT7071 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-D6) - HRP | LEI-LT7072 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E2) | LEI-LT7040 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E2) - Biotin | LEI-LT7041 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E2) - HRP | LEI-LT7042 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E6) | LEI-LT7090 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E6) - Biotin | LEI-LT7091 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E6) - HRP | LEI-LT7092 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E9) | LEI-LT7015 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E9) - Biotin | LEI-LT7016 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-E9) - HRP | LEI-LT7017 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-F3) | LEI-LT7050 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-F3) - Biotin | LEI-LT7051 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-F3) - HRP | LEI-LT7052 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-F9) | LEI-LT7005 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-F9) - Biotin | LEI-LT7006 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-F9) - HRP | LEI-LT7007 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-B1) | LEI-LT7020 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-B1) - Biotin | LEI-LT7021 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-B1) - HRP | LEI-LT7022 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-D8) | LEI-LT7010 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-D8) - Biotin | LEI-LT7011 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-D8) - HRP | LEI-LT7012 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-F6) | LEI-LT7025 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-F6) - Biotin | LEI-LT7026 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP2-F6) - HRP | LEI-LT7027 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike (Clone: 2143) | LEI-LT3500 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike (CT) | LEI-S540 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike Antibody [Clone LGSV201] | LDG0086YA | LeadGene Biomedical | Summary Details |
|
Anti-SARS-CoV-2 Spike NTD (Clone 2146) | LEI-LT2000 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike NTD (Clone 2146) - Biotin | LEI-LT2005 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike NTD (Clone 2146) - HRP | LEI-LT2010 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike NTD (Clone 2215) | LEI-LT6000 | Leinco Technologies | Summary Details |
|
anti-SARS-CoV-2 Spike Protein S1 mAb (rec.) (blocking) (Covi-1) (preservative free) | AG-27B-6005PF | AdipoGen Life Sciences | Summary Details |
|
anti-SARS-CoV-2 Spike Protein S1 mAb (rec.) (blocking) (Covi-2) (preservative free) | AG-27B-6006PF | AdipoGen Life Sciences | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone 2165) - Biotin | LEI-LT1905 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone 2165) - HRP | LEI-LT1910 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone 2196) - Biotin | LEI-LT8005 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone 2196) - HRP | LEI-LT8010 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone: 2130) | LEI-LT8050 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone: 2165) | LEI-LT1900 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone: 2196) | LEI-LT8000 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone: 2355) | LEI-LT5000 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone: 2381) | LEI-LT4000 | Leinco Technologies | Summary Details |
|
Anti-SARS-CoV-2 Spike RBD (Clone: 2838) | LEI-LT3000 | Leinco Technologies | Summary Details |
|
Bebtelovimab (LY-CoV1404/LY3853113) Antibody, Monoclonal | PSI-21-847 | ProSci | Summary Details |
|
Biotinylated Human ACE2 Recombinant Protein | PSI-10-202 | ProSci | Summary Details |
|
Biotinylated SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein | PSI-11-165 | ProSci | Summary Details |
|
Coronavirus Nucleoprotein Antibody [3877] | PSI-35-716 | ProSci | Summary Details |
|
Coronavirus Nucleoprotein Antibody [3878] | PSI-35-717 | ProSci | Summary Details |
|
Coronavirus Nucleoprotein Antibody [3879] | PSI-35-718 | ProSci | Summary Details |
|
CoV-2/COVID-19 Spike Glycoprotein recombinant monoclonal antibody, clone CR3022? | RAB03810 | Abnova Corporation | Summary Details |
|
Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Human IgA1 | PSI-24-831 | ProSci | Summary Details |
|
Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Human IgG1 | PSI-24-829 | ProSci | Summary Details |
|
Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Human IgM | PSI-24-830 | ProSci | Summary Details |
|
Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Rabbit IgG | PSI-24-832 | ProSci | Summary Details |
|
Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgA1 | PSI-24-827 | ProSci | Summary Details |
|
Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgG1 | PSI-24-825 | ProSci | Summary Details |
|
Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgM | PSI-24-826 | ProSci | Summary Details |
|
Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Rabbit IgG | PSI-24-828 | ProSci | Summary Details |
|
COVID-19 & SARS-CoV S glycoprotein Antibody [CR3022], Human IgA1 | PSI-24-807 | ProSci | Summary Details |
|
COVID-19 & SARS-CoV S glycoprotein Antibody [CR3022], Human IgG1 | PSI-24-805 | ProSci | Summary Details |
|
COVID-19 & SARS-CoV S glycoprotein Antibody [CR3022], Human IgM | PSI-24-806 | ProSci | Summary Details |
|
COVID-19 & SARS-CoV S glycoprotein Antibody [CR3022], Mouse IgG2b | PSI-24-809 | ProSci | Summary Details |
|
COVID-19 & SARS-CoV S glycoprotein Antibody [CR3022], Rabbit IgG | PSI-24-808 | ProSci | Summary Details |
|
COVID-19 Delta Variant Neutralizing Antibody ELISA Kit | KA6323 | Abnova Corporation | Summary Details |
|
COVID-19 Human IgM IgG Assay Kit | KA5826 | Abnova Corporation | Summary Details |
|
COVID-19 IgG/IgM Rapid Test Kit | UNCOV | Elabscience | Summary Details |
|
COVID-19 Neutralizing Antibody ELISA Kit | KA6111 | Abnova Corporation | Summary Details |
|
COVID-19 Pseudovirus Neutralizing Antibody Assay (Luciferase) | KA6152 | Abnova Corporation | Summary Details |
|
COVID-19 Spike Protein mRNA-LNP | TAR-T75116 | TargetMol | Summary Details |
|
COVID-19 Spike Protein mRNA(N1-Me-Pseudo UTP) | TAR-T75102 | TargetMol | Summary Details |
|
COVID-19 Viral Antigen N ELISA Kit | KA6067 | Abnova Corporation | Summary Details |
|
COVID-19 Viral Antigen S ELISA Kit | KA6066 | Abnova Corporation | Summary Details |
|
GENLISA™ Guinea Pig Anti-SARS-CoV-2 (Covid-19) IgG Antibody to spike RBD protein Quantitative TITRATION ELISA | KBVH015-42 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Hamster Anti-SARS-CoV-2 (Covid-19) IgG to spike RBD Delta/Delta Plus Variant (B.1.617.2,AY.1,AY.2) Quantitative TITRATION ELISA | KBVH015-51 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) IgG Antibody to Spike protein S1 Quantitative TITRATION ELISA | KBVH015-28 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) IgG Antibody to Spike protein S2 Quantitative TITRATION ELISA | KBVH015-29 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) IgG Antibody to spike S1+S2 ECD protein Quantitative TITRATION ELISA | KBVH015-21 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) IgG to nucleoprotein Omicron Variant (B.1.1.529)+Delta (B.1.617.2) Quantitative TITRATION ELISA | KBVH015-50 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) IgG to spike RBD Delta/Delta Plus Variant (B.1.617.2, AY.1,AY.2) Quantitative TITRATION ELISA | KBVH015-45 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) IgG to spike RBD Omicron Variant (B.1.1.529) Quantitative TITRATION ELISA | KBVH015-43 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) IgG to spike S1+S2 Delta/Delta Plus Variant (B.1.617.2, AY.1,AY.2) Quantitative TITRATION ELISA | KBVH015-46 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) Nucleocapsid Protein IgG ELISA - CE MARKED | KBVH015-3 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human Anti-SARS-CoV-2 (Covid-19) Spike Protein IgG ELISA - CE MARKED | KBVH015-2 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human SARS-CoV-2 (Covid-19) Envelope Protein Antigen Quantitative TITRATION ELISA | KBVH015-30 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human SARS-CoV-2 (Covid-19) Membrane Protein Antigen Quantitative TITRATION ELISA | KBVH015-31 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human SARS-CoV-2 (Covid-19) Nucleocapsid Omicron Variant (B.1.1.529) Antigen Quantitative TITRATION ELISA | KBVH015-47 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human SARS-CoV-2 (Covid-19) Spike Protein S1 Antigen Quantitative ELISA | KBVH015-10 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human SARS-CoV-2 (Covid-19) Spike RBD Omicron Variant (B.1.1.529) Antigen Quantitative TITRATION ELISA | KBVH015-48 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human SARS-CoV-2 (Covid-19) spike RBD protein Delta Variant (B.1.617.2) Antigen Quantitative TITRATION ELISA | KBVH015-44 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Human SARS-CoV-2 (Covid-19) Spike S2 Omicron Variant (B.1.1.529) Antigen Quantitative TITRATION ELISA | KBVH015-49 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG Antibody to Nucleocapsid protein Quantitative TITRATION ELISA | KBVH015-16 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG Antibody to Spike RBD protein Quantitative TITRATION ELISA | KBVH015-13 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG Antibody to Spike S1 protein Quantitative TITRATION ELISA | KBVH015-14 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG Antibody to spike S1+S2 ECD protein Quantitative TITRATION ELISA | KBVH015-15 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG Antibody to whole spike protein Quantitative TITRATION ELISA | KBVH015-52 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG1 Antibody to whole spike protein Quantitative TITRATION ELISA | KBVH015-53 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG2a Antibody to whole spike protein Quantitative TITRATION ELISA | KBVH015-54 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG2b Antibody to whole spike protein Quantitative TITRATION ELISA | KBVH015-55 | Krishgen Biosystems | Summary Details |
|
GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) to Spike RBD mutation K417N, E484K, N501Y (South African Variant) Quantitative TITRATION ELISA | KBVH015-32 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) (Wild Type+South African Variant) RBD Antigen Quantitative TITRATION ELISA | KBVH015-41 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Alpha Neutralizing Antibody (B.1.1.7) ELISA | KBVH410 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Beta Neutralizing Antibody (B.1.351, B.1.351.2,B.1.351.3) ELISA | KBVH420 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Delta/DeltaPlus Neutralizing Antibody (B.1.617.2, AY.1,AY.2) ELISA | KBVH430 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Epsilon Neutralizing Antibody (B.1.429,B.1.427) ELISA | KBVH440 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Gamma Neutralizing Antibody (P.1,P.1.1,P.1.2) ELISA | KBVH450 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Iota Neutralizing Antibody (B.1.526) ELISA | KBVH460 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Kappa Neutralizing Antibody (B.1.617.2) ELISA | KBVH470 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Lambda Neutralizing Antibody (C.37) ELISA | KBVH480 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Mu Neutralizing Antibody (B.1.621) ELISA | KBVH490 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Neutralizing Antibody ELISA | KBVH400 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Neutralizing Antibody S1 mutation D614G ELISA | KBVH500 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Omicron Neutralizing Antibody (B.1.1.529) ELISA | KBVH520 | Krishgen Biosystems | Summary Details |
|
GENLISA™ SARS-CoV-2 (Covid-19) Omicron Neutralizing Antibody [S1+S2 Trimer] (B.1.1.529) ELISA | KBVH510 | Krishgen Biosystems | Summary Details |
|
GM-CSF Antibody | PSI-38-330 | ProSci | Summary Details |
|
GM-CSF Antibody (biotin) | PSI-38-331 | ProSci | Summary Details |
|
HCoV-229E Nucleocapsid Protein, His Tag, E. coli | LDG009PVE | LeadGene Biomedical | Summary Details |
|
HCoV-229E Nucleocapsid Recombinant Protein | PSI-11-163 | ProSci | Summary Details |
|
HCoV-229E S1 Recombinant Protein | PSI-11-196 | ProSci | Summary Details |
|
HCoV-HKU1 Nucleocapsid Protein, His Tag, E. coli | LDG008PVE | LeadGene Biomedical | Summary Details |
|
HCoV-HKU1(isolate N5) S1 Recombinant Protein | PSI-11-195 | ProSci | Summary Details |
|
HCoV-NL63 Nucleocapsid Protein, His-SUMO Tag, HEK293 | LDG003PVM | LeadGene Biomedical | Summary Details |
|
HCoV-NL63 S1 Recombinant Protein | PSI-11-197 | ProSci | Summary Details |
|
HCoV-OC43 Nucleocapsid Protein, His Tag, E. coli | LDG007PVE | LeadGene Biomedical | Summary Details |
|
Human ACE2 Recombinant Protein | PSI-10-114 | ProSci | Summary Details |
|
Human ACE2 Recombinant Protein | PSI-10-120 | ProSci | Summary Details |
|
Human ACE2 Recombinant Protein | PSI-10-200 | ProSci | Summary Details |
|
Human ACE2 Recombinant Protein | PSI-10-203 | ProSci | Summary Details |
|
Human ACE2, Fc Tag, HEK293 | LDG009PHM | LeadGene Biomedical | Summary Details |
|
Human Coronavirus 229E Nucleocapsid Antibody | PSI-20-268 | ProSci | Summary Details |
|
Human Coronavirus 229E Recombinant protein | PSI-39-101 | ProSci | Summary Details |
|
Human Coronavirus NL63 Recombinant protein | PSI-39-103 | ProSci | Summary Details |
|
Human Coronavirus OC43 Nucleocapsid Antibody | PSI-20-267 | ProSci | Summary Details |
|
Human COVID-19 IgG/IgM Lateral Flow Assay Kit | E-HD-C060 | Elabscience | Summary Details |
|
Human SARS-CoV-2 Nucleocapsid ELISA Kit | ELK-ECV001 | ELK Biotechnology | Summary Details |
|
IL-1 beta Antibody | PSI-38-306 | ProSci | Summary Details |
|
IL-1 beta Antibody | PSI-38-313 | ProSci | Summary Details |
|
IL-1 beta Antibody (biotin) | PSI-38-314 | ProSci | Summary Details |
|
IL-10 Antibody | PSI-38-312 | ProSci | Summary Details |
|
IL-12 Antibody | PSI-38-309 | ProSci | Summary Details |
|
IL-12 Antibody | PSI-38-311 | ProSci | Summary Details |
|
IL-12 Antibody | PSI-38-339 | ProSci | Summary Details |
|
IL-12 Antibody | PSI-38-341 | ProSci | Summary Details |
|
IL-12 Antibody (biotin) | PSI-38-340 | ProSci | Summary Details |
|
IL-12 Antibody (biotin) | PSI-38-342 | ProSci | Summary Details |
|
IL-13 Antibody | PSI-38-344 | ProSci | Summary Details |
|
IL-13 Antibody (biotin) | PSI-38-345 | ProSci | Summary Details |
|
IL-2 Antibody | PSI-38-307 | ProSci | Summary Details |
|
IL-2 Antibody [1Q8G7] | PSI-11-090 | ProSci | Summary Details |
|
IL-2 Antibody [4N2Q9] | PSI-11-089 | ProSci | Summary Details |
|
IL-4 Antibody | PSI-38-328 | ProSci | Summary Details |
|
IL-4 Antibody (biotin) | PSI-38-329 | ProSci | Summary Details |
|
IL-6 Antibody [2M8M3] | PSI-11-094 | ProSci | Summary Details |
|
IL-6 Antibody [8L8T2] | PSI-11-095 | ProSci | Summary Details |
|
MERS Coronavirus (HSZ-Cc) Envelope Antibody | PSI-20-286 | ProSci | Summary Details |
|
MERS Coronavirus (HSZ-Cc) Membrane Antibody | PSI-20-273 | ProSci | Summary Details |
|
MERS Coronavirus (HSZ-Cc) Nucleocapsid Antibody | PSI-20-270 | ProSci | Summary Details |
|
MERS Coronavirus (HSZ-Cc) Spike Antibody | PSI-20-263 | ProSci | Summary Details |
|
MERS Coronavirus Antibody [3871] | PSI-35-713 | ProSci | Summary Details |
|
MERS Coronavirus Antibody [3872] | PSI-35-714 | ProSci | Summary Details |
|
MERS Coronavirus Antibody [3873] | PSI-35-715 | ProSci | Summary Details |
|
MERS Nucleocapsid Recombinant Protein | PSI-11-177 | ProSci | Summary Details |
|
MERS S Recombinant Protein RBD | PSI-11-178 | ProSci | Summary Details |
|
MERS S1 Recombinant Protein | PSI-11-150 | ProSci | Summary Details |
|
MERS Spike S1 Recombinant protein | PSI-39-102 | ProSci | Summary Details |
|
MERS-CoV Nucleocapsid Protein, His-SUMO Tag, HEK293 | LDG004PVM | LeadGene Biomedical | Summary Details |
|
Monkey CTSL (Cathepsin L) ELISA Kit | E-EL-MK2294 | Elabscience | Summary Details |
|
Monkey CTSL Antibody Pair Set | E-KAB-0659 | Elabscience | Summary Details |
|
Nasal Cavity Swabs - Tested Covid-19 Negative - 1 Sample | 991-31-NCV-COVID-N-1 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Cavity Swabs - Tested Covid-19 Positive - 1 Sample | 991-31-NCV-COVID-1 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Fluid, Pooled Donors - COVID-19 Negative (Confirmed) - 1 Sample (1mL) | 991-13-P-COVID-N-1 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Fluid, Pooled Donors - COVID-19 Negative (Confirmed) - 1 x 10 mL | 991-13-P-COVID-N-10 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Fluid, Pooled Donors - COVID-19 Positive (Confirmed) - 1 Sample (1mL) | 991-13-P-COVID-1 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Fluid, Single Human Donor - COVID-19 Negative (Confirmed) - 1 Sample (0.5mL) | 991-13-S-COVID-N-0.5 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Fluid, Single Human Donor - COVID-19 Negative (Confirmed) - 1 Sample (10 mL) | 991-13-S-COVID-N-10 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Fluid, Single Human Donor - COVID-19 Negative (Confirmed) - 1 Sample (1mL) | 991-13-S-COVID-N-1 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Fluid, Single Human Donor - COVID-19 Negative (Confirmed) - 1 Sample (50 mL) | 991-13-S-COVID-N-50 | Caltag Medsystems Ltd. | Summary Details |
|
Nasal Fluid, Single Human Donor - COVID-19 Negative (Confirmed) - 5 Samples (5 x 1mL) | 991-13-S-COVID-N-5S | Caltag Medsystems Ltd. | Summary Details |
|
Novel Coronavirus 2019-nCoV Spike Glycoprotein-S1, Recombinant protein | PSI-39-111 | ProSci | Summary Details |
|
Novel Coronavirus 2019-nCoV Spike Glycoprotein-S2, Recombinant protein | PSI-39-112 | ProSci | Summary Details |
|
One-Step TaqProbe RT-qPCR Master Mix, 4x 1.5mL | SC-MB802 | Sciencell | Summary Details |
|
PLpro (SARS Coronavirus) (rec.) (His) | SBB-DE0024 | South Bay Bio | Summary Details |
|
RBD Enzyme Conjugate (100X) | LEI-S861 | Leinco Technologies | Summary Details |
|
Recombinant 2019-nCoV S2 Protein (Fc Tag) | PKSR030491 | Elabscience | Summary Details |
|
Recombinant ACE2 Antibody, monoclonal | PSI-11-028 | ProSci | Summary Details |
|
Recombinant CoV-2/COVID-19 Spike Glycoprotein Antibody | PSI-10-709 | ProSci | Summary Details |
|
Recombinant Human ACE2 (HEK Expressed) | LEI-S856 | Leinco Technologies | Summary Details |
|
Recombinant Nucleoprotein (NP), N-terminal His Tag | RPX274Ge01 | Cloud-Clone Corp. | Summary Details |
|
Recombinant SARS-CoV-2 (2019-nCoV) S protein RBD (C-mFc-6His tag)(Active) | PKSV030276 | Elabscience | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) (S1) -1 Antibody [CR3022] | PSI-10-706 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) (S1) -2 Antibody [CR3022] | PSI-10-703 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) (S1) -3 Antibody [H4] | PSI-10-707 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) (S1) -4 Antibody [B38] | PSI-10-708 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid antibody | PSI-10-721 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid antibody | PSI-10-722 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv Antibody [4A6] | PSI-93-301 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6] | PSI-93-302 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) RBD Neutralizing antibody [AbA128] | PSI-11-023 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) RBD Neutralizing antibody [AbE450] | PSI-11-024 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) RBD Neutralizing antibody [AbG106] | PSI-11-022 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbB101] | PSI-11-057 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbB301] | PSI-11-029 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbB501] | PSI-11-056 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbD102] | PSI-11-058 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbD103] | PSI-11-060 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbF712] | PSI-11-026 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbF804] | PSI-11-063 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbG503] | PSI-11-061 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (COVID-19) S2 antibody [AbH722] | PSI-11-027 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 (S1) -1 Neutralizing antibody Antibody | PSI-10-711 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 RBD antibody | PSI-10-718 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 RBD antibody | PSI-10-715 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 RBD antibody | PSI-10-713 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2 S-NTD antibody | PSI-10-717 | ProSci | Summary Details |
|
Recombinant SARS-CoV-2, NTD Protein | LEI-S853 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, Nucleocapsid (N) Protein | LEI-S854 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, RBD Protein | LEI-S851 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, RBD Protein (Alpha, B1.1.7, UK Variant) | LEI-S351 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, RBD Protein (Beta, B1.351, South Africa Variant) | LEI-S151 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, RBD Protein (Delta Plus, B1.617.2.1, AY.1, India Variant) | LEI-S952 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, RBD Protein (Delta, B1.617.2, India Variant ) | LEI-S951 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, RBD Protein (Gamma, P.1, Brazil Variant) | LEI-S251 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, RBD Protein (Kappa, B1.617.1, India Variant) | LEI-S451 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, S1-mFc Protein | LEI-S855 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, S2 Protein | LEI-S850 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2, Trimeric Spike (S) Protein | LEI-S848 | Leinco Technologies | Summary Details |
|
Recombinant SARS-CoV-2(S1)-6 antibody | PSI-10-712 | ProSci | Summary Details |
|
Recombinant Spike Protein (SP), N-terminal His Tag | RPX273Ge01 | Cloud-Clone Corp. | Summary Details |
|
Recombinant Spike Protein (SP), N-terminal His Tag | RPX273Ge03 | Cloud-Clone Corp. | Summary Details |
|
Recombinant-SARS-CoV-2 (COVID-19) RBD Neutralizing Antibody [S2E12] | PSI-21-848 | ProSci | Summary Details |
|
Recombinant-SARS-CoV-2 (COVID-19) RBD Neutralizing Antibody [S2H97] | PSI-21-849 | ProSci | Summary Details |
|
SARS (IN1) Spike Peptide | PSI-3221P | ProSci | Summary Details |
|
SARS (IN2) Spike Peptide | PSI-3223P | ProSci | Summary Details |
|
SARS (IN3) Spike Peptide | PSI-3225P | ProSci | Summary Details |
|
SARS Biotinylated Spike RBD Recombinant Protein | PSI-10-212 | ProSci | Summary Details |
|
SARS Coronavirus (HSZ-Cc) Envelope Antibody | PSI-20-285 | ProSci | Summary Details |
|
SARS Coronavirus (HSZ-Cc) Membrane Antibody | PSI-20-272 | ProSci | Summary Details |
|
SARS Coronavirus (HSZ-Cc) Nucleocapsid Antibody | PSI-20-271 | ProSci | Summary Details |
|
SARS Coronavirus (HSZ-Cc) Spike Antibody | PSI-20-262 | ProSci | Summary Details |
|
SARS Coronavirus Antibody [3851] | PSI-35-579 | ProSci | Summary Details |
|
SARS Coronavirus Antibody [3861] | PSI-35-580 | ProSci | Summary Details |
|
SARS Coronavirus Envelope Recombinant Protein | PSI-39-104 | ProSci | Summary Details |
|
SARS Coronavirus Envelope Recombinant Protein | PSI-39-118 | ProSci | Summary Details |
|
SARS Coronavirus Matrix Recombinant protein | PSI-39-117 | ProSci | Summary Details |
|
SARS Coronavirus Membrane Recombinant protein | PSI-39-107 | ProSci | Summary Details |
|
SARS Coronavirus Mosaic Recombinant protein | PSI-39-110 | ProSci | Summary Details |
|
SARS Coronavirus Nucleocapsid Core Recombinant protein | PSI-39-121 | ProSci | Summary Details |
|
SARS Coronavirus Nucleocapsid Core Recombinant protein (1-49 aa) | PSI-39-119 | ProSci | Summary Details |
|
SARS Coronavirus Nucleocapsid Core Recombinant protein (340-390 aa) | PSI-39-120 | ProSci | Summary Details |
|
SARS Coronavirus Nucleocapsid Recombinant protein (1-49 aa) | PSI-39-105 | ProSci | Summary Details |
|
SARS Coronavirus Nucleocapsid Recombinant protein (340-390 aa) | PSI-39-106 | ProSci | Summary Details |
|
SARS Coronavirus Nucleocapsid Recombinant protein (422aa) | PSI-39-116 | ProSci | Summary Details |
|
SARS Coronavirus Spike Recombinant protein (408-470, 540-573 aa) | PSI-39-109 | ProSci | Summary Details |
|
SARS Coronavirus Spike Mosaic Recombinant protein (C-terminus) | PSI-39-123 | ProSci | Summary Details |
|
SARS Coronavirus Spike Mosaic Recombinant protein (Center) | PSI-39-122 | ProSci | Summary Details |
|
SARS Coronavirus Spike Mosaic Recombinant protein (N-terminus) | PSI-39-124 | ProSci | Summary Details |
|
SARS Coronavirus Spike Recombinant protein (1-53, 90-115, 171-205 aa) | PSI-39-108 | ProSci | Summary Details |
|
SARS CoV-2 full length spike protein in DIBMA Glycerol | PSI-21-816 | ProSci | Summary Details |
|
SARS CoV-2 full length spike protein in LMNG detergent | PSI-21-815 | ProSci | Summary Details |
|
SARS CoV-2 full length spike protein nanodisc complex | PSI-21-817 | ProSci | Summary Details |
|
SARS Envelope Antibody | PSI-3531 | ProSci | Summary Details |
|
SARS Envelope Antibody | PSI-3533 | ProSci | Summary Details |
|
SARS Envelope Peptide | PSI-3531P | ProSci | Summary Details |
|
SARS Envelope Peptide | PSI-3533P | ProSci | Summary Details |
|
SARS Matrix Antibody | PSI-3527 | ProSci | Summary Details |
|
SARS Matrix Antibody | PSI-3529 | ProSci | Summary Details |
|
SARS Matrix Peptide | PSI-3527P | ProSci | Summary Details |
|
SARS Matrix Peptide | PSI-3529P | ProSci | Summary Details |
|
SARS Nucleocapsid Antibody | PSI-10-650 | ProSci | Summary Details |
|
SARS Nucleocapsid Antibody [14B3D] | PSI-10-648 | ProSci | Summary Details |
|
SARS Nucleocapsid Antibody [5B1B] | PSI-10-645 | ProSci | Summary Details |
|
SARS Nucleocapsid Antibody [5C6C] | PSI-10-646 | ProSci | Summary Details |
|
SARS Nucleocapsid Antibody [5C6C] (HRP) | PSI-10-647 | ProSci | Summary Details |
|
SARS Nucleocapsid Antibody [7C2B] | PSI-10-649 | ProSci | Summary Details |
|
SARS Nucleocapsid Antibody [8G8A] | PSI-10-643 | ProSci | Summary Details |
|
SARS Nucleocapsid Antibody [8G8A] (HRP) | PSI-10-644 | ProSci | Summary Details |
|
SARS ORF1a Polyprotein Antibody | PSI-10-627 | ProSci | Summary Details |
|
SARS ORF1a Polyprotein Antibody (Biotin) | PSI-10-639 | ProSci | Summary Details |
|
SARS ORF1a Polyprotein Antibody (Cy3) | PSI-10-633 | ProSci | Summary Details |
|
SARS ORF1a Polyprotein Antibody (Cy5.5) | PSI-10-636 | ProSci | Summary Details |
|
SARS ORF1a Polyprotein Antibody (Cy5) | PSI-10-634 | ProSci | Summary Details |
|
SARS ORF1a Polyprotein Antibody (Cy7) | PSI-10-637 | ProSci | Summary Details |
|
SARS ORF1a Polyprotein Antibody (FITC) | PSI-10-638 | ProSci | Summary Details |
|
SARS ORF1a Polyprotein Antibody (HRP) | PSI-10-640 | ProSci | Summary Details |
|
SARS Spike Antibody | PSI-3219 | ProSci | Summary Details |
|
SARS Spike Antibody | PSI-3221 | ProSci | Summary Details |
|
SARS Spike Antibody | PSI-3223 | ProSci | Summary Details |
|
SARS Spike Antibody | PSI-3225 | ProSci | Summary Details |
|
SARS Spike Antibody | PSI-3525 | ProSci | Summary Details |
|
SARS Spike Antibody | PSI-10-611 | ProSci | Summary Details |
|
SARS Spike Antibody (Biotin) | PSI-10-622 | ProSci | Summary Details |
|
SARS Spike Antibody (Cy3) | PSI-10-617 | ProSci | Summary Details |
|
SARS Spike Antibody (Cy5.5) | PSI-10-619 | ProSci | Summary Details |
|
SARS Spike Antibody (Cy5) | PSI-10-618 | ProSci | Summary Details |
|
SARS Spike Antibody (Cy7) | PSI-10-620 | ProSci | Summary Details |
|
SARS Spike Antibody (FITC) | PSI-10-621 | ProSci | Summary Details |
|
SARS Spike Antibody (HRP) | PSI-10-623 | ProSci | Summary Details |
|
SARS Spike Glycoprotein S1 Antibody | PSI-10-626 | ProSci | Summary Details |
|
SARS Spike Peptide | PSI-3219P | ProSci | Summary Details |
|
SARS Spike Peptide | PSI-3525P | ProSci | Summary Details |
|
SARS Spike RBD Recombinant Protein | PSI-10-211 | ProSci | Summary Details |
|
SARS-CoV Nucleocapsid Protein, His-SUMO Tag, HEK293 | LDG005PVM | LeadGene Biomedical | Summary Details |
|
SARS-CoV Nucleocapsid Recombinant Protein | PSI-11-173 | ProSci | Summary Details |
|
SARS-CoV-1 Pseudovirus | PSI-95-204 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleoprotein Antibody [3862] | PSI-35-710 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleoprotein Antibody [3863] | PSI-35-711 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleoprotein Antibody [3864] | PSI-35-712 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) 3C-like Proteinase | PSI-10-116 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) 3C-like Proteinase Recombinant Protein | PSI-10-412 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) 3CL-PRO (NSP5) Antibody | PSI-9151 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) 3CL-PRO (NSP5) Antibody | PSI-9153 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) 3CL-PRO (NSP5) Peptide | PSI-9151P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) 3CL-PRO (NSP5) Peptide | PSI-9153P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) 501Y.V2/V3 variant S RBD (E484K) Recombinant Protein | PSI-11-067 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide | PSI-9359P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike RBD Recombinant Protein | PSI-21-824 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein | PSI-21-808 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein | PSI-21-811 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Beta Variant ( B.1.351, SA) Spike RBD Recombinant Protein | PSI-21-825 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike S1 (RBD) Recombinant Protein | PSI-21-809 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike S1 (RBD) Recombinant Protein | PSI-21-812 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Biotinylated Spike RBD Recombinant Protein | PSI-10-205 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Biotinylated Spike S1 Recombinant Protein | PSI-10-208 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Brazil variant (501Y.V3) S RBD (K417T, E484K, N501Y) Recombinant Protein | PSI-11-066 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Delta plus Variant (B.1.617.2.1) Spike RBD (K417N, T478K, L452R) Recombinant Protein | PSI-21-827 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Delta Variant (B.1.617.2) Spike RBD (L452R, T478K) Recombinant Protein | PSI-21-831 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Delta Variant Spike RBD (His-Avi Tag) Recombinant Protein | PSI-95-126 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Delta Variant Spike S1 (His-Avi Tag) Recombinant Protein | PSI-95-127 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) E protein polyclonal antibody | PSI-11-051 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) E Recombinant Protein | PSI-11-072 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Antibody | PSI-9169 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Antibody | PSI-20-274 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Antibody (biotin) | PSI-3531-biotin | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Antibody (CT) | PSI-10-518 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Antibody (HRP) | PSI-3531-HRP | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Peptide | PSI-9169P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Recombinant Protein | PSI-10-112 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Recombinant Protein | PSI-92-730 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Recombinant Protein | PSI-20-205 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Envelope Recombinant Protein | PSI-20-231 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Full-Length Alpha Variant (B.1.1.7, UK) Spike Recombinant Protein | PSI-21-818 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Full-Length Beta Variant (B.1.351, SA) Spike Recombinant Protein | PSI-21-819 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Full-Length Epsilon Variant (B.1.429, Ca) Spike Recombinant Protein | PSI-21-822 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Full-Length Eta Variant (B.1.525, UK) Spike Recombinant Protein | PSI-21-821 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Full-Length Gamma Variant (P.1, Brazil) Spike Recombinant Protein | PSI-21-820 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Full-Length Kappa Variant (B.1.617.1, India) Spike Recombinant Protein | PSI-21-823 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Gamma Variant (P.1, Brazil) Spike RBD Recombinant Protein | PSI-21-826 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Gamma Variant (P.1, Brazil) Spike S1 (RBD) Variant Recombinant Protein | PSI-21-810 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Gamma Variant (P.1, Brazil) Spike S1 (RBD) Variant Recombinant Protein | PSI-21-813 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Helicase Recombinant Protein | PSI-92-765 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Kappa Variant (B.1.617, India) Spike RBD (E484Q, L452R) Recombinant Protein | PSI-20-185 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Lambda Variant (B.1.1.1/C.37) Spike RBD (L452Q, F490S) Recombinant Protein | PSI-21-828 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) M protein polyclonal antibody | PSI-11-035 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) M Recombinant Protein | PSI-10-429 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Antibody | PSI-9157 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Antibody | PSI-9165 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Antibody | PSI-20-275 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Antibody (biotin) | PSI-9157-biotin | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Antibody (HRP) | PSI-9157-HRP | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Antibody (IN) | PSI-10-516 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Peptide | PSI-9157P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Peptide | PSI-9165P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Recombinant Protein | PSI-20-203 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Membrane Recombinant Protein | PSI-20-230 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Mu Variant (B.1.621) Spike RBD (R346K, E484K, N501Y, D614G, P681H) Recombinant Protein | PSI-21-830 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NP CTD domain Recombinant Protein | PSI-92-735 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP1 Antibody | PSI-20-281 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP1 polyclonal antibody | PSI-11-044 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein | PSI-10-416 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein | PSI-92-764 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein | PSI-20-218 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein | PSI-20-255 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP10 Antibody | PSI-9179 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP10 Antibody | PSI-20-290 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP10 PC Antibody | PSI-20-257 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP10 Peptide | PSI-9179P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP10 polyclonal antibody | PSI-11-047 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP10 Recombinant Protein | PSI-10-408 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP10 Recombinant Protein | PSI-20-211 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP10 Recombinant Protein | PSI-20-248 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP11 NSP12 Antibody | PSI-20-265 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP11 NSP12 Recombinant Protein | PSI-20-210 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP11 NSP12 Recombinant Protein | PSI-20-247 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP12 Antibody | PSI-9267 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP12 Peptide | PSI-9267P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP12 polyclonal antibody | PSI-11-036 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody | PSI-9181 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody | PSI-9183 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP13 (Helicase) Peptide | PSI-9181P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP13 (Helicase) Peptide | PSI-9183P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP13 Antibody | PSI-20-278 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) Nsp13 polyclonal antibody | PSI-11-033 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP13 Recombinant Protein | PSI-10-427 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP13 Recombinant Protein | PSI-20-209 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP13 Recombinant Protein | PSI-20-246 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP14 (ExoN) Antibody | PSI-9185 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP14 (ExoN) Antibody | PSI-9187 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP14 (ExoN) Peptide | PSI-9185P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP14 (ExoN) Peptide | PSI-9187P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP14 Antibody | PSI-20-256 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP14 Antibody | PSI-20-277 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP14 Recombinant Protein | PSI-20-208 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP14 Recombinant Protein | PSI-20-245 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP15 Antibody | PSI-9269 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP15 Antibody | PSI-20-264 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP15 Peptide | PSI-9269P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP15 Recombinant Protein | PSI-20-207 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP15 Recombinant Protein | PSI-20-244 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP16 Antibody | PSI-9271 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP16 Antibody | PSI-20-276 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP16 Peptide | PSI-9271P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP16 polyclonal antibody | PSI-11-046 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP16 Recombinant Protein | PSI-20-206 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP16 Recombinant Protein | PSI-20-243 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP2 Antibody | PSI-9171 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP2 Antibody | PSI-9173 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP2 Antibody | PSI-20-280 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP2 Peptide | PSI-9171P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP2 Peptide | PSI-9173P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein | PSI-10-425 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein | PSI-20-217 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein | PSI-20-254 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP3 (743 - 1072) Antibody | PSI-20-258 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP3 (743 - 1072) Recombinant Protein | PSI-20-216 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP3 (743 - 1072) Recombinant Protein | PSI-20-253 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP3 polyclonal antibody | PSI-11-030 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP3 Recombinant Protein | PSI-10-406 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP4 Antibody | PSI-9175 | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP4 Peptide | PSI-9175P | ProSci | Summary Details |
|
SARS-CoV-2 (COVID-19) NSP5 Antibody | PSI-20-266 | ProSci | Summary Details |
|
Share |